OCM
Objective Capital Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,604
| Closed | -$285K | – | 78 |
|
2024
Q4 | $285K | Sell |
1,604
-287
| -15% | -$51K | 0.19% | 106 |
|
2024
Q3 | $373K | Buy |
+1,891
| New | +$373K | 0.22% | 96 |
|
2024
Q1 | $393K | Buy |
2,159
+74
| +4% | +$13.5K | 0.27% | 82 |
|
2023
Q4 | $323K | Sell |
2,085
-135
| -6% | -$20.9K | 0.25% | 87 |
|
2023
Q3 | $331K | Sell |
2,220
-122
| -5% | -$18.2K | 0.29% | 69 |
|
2023
Q2 | $316K | Buy |
2,342
+130
| +6% | +$17.5K | 0.28% | 70 |
|
2023
Q1 | $353K | Sell |
2,212
-66
| -3% | -$10.5K | 0.32% | 65 |
|
2022
Q4 | $368K | Buy |
2,278
+86
| +4% | +$13.9K | 0.37% | 63 |
|
2022
Q3 | $294K | Buy |
2,192
+28
| +1% | +$3.76K | 0.31% | 69 |
|
2022
Q2 | $331K | Sell |
2,164
-5
| -0.2% | -$765 | 0.33% | 70 |
|
2022
Q1 | $352K | Buy |
2,169
+1
| +0% | +$162 | 0.27% | 80 |
|
2021
Q4 | $294K | Buy |
+2,168
| New | +$294K | 0.21% | 89 |
|